Stryker (NYSE: SYK )
has been a fairly strong stock this year, and why not? The company
addresses several attractive markets within med-tech and shown a
willingness (and capability) to effectively deploy capital toward
business-building M&A transactions. Although price weakness,
particularly in ortho, is a concern and the stock's valuation isn't a
screaming bargain, Stryker likely won't be a bad place to be relative to
the sector.
Continue here:
Stryker Corporation Stock Coming Through With Growth
No comments:
Post a Comment